GPBAR1 and cancer: In various cancer types, GPCRs and their signaling pathways are known to be altered via multiple mechanisms, including elevated expression, mutations, aberrant expression of downstream G proteins, increased production of GPCR activating ligands, or aberrant expression of GRKs.